Zobrazeno 1 - 10 of 1 343 pro vyhledávání: '"Koc, J"'
1
Akademický článek
Trained Mesenchymal Stromal Cell-Based Therapy HXB-319 for Treating Diffuse Alveolar Hemorrhage in a Pristane-induced Murine Model.
Autor: Bukulmez H; Division of Pediatric Rheumatology, Department of Pediatrics, Metrohealth Medical Center, Case Western Reserve University, Cleveland, Ohio., Dennis AT; Division of Pediatric Rheumatology, Department of Pediatrics, Metrohealth Medical Center, Case Western Reserve University, Cleveland, Ohio., Reese-Koc J; Cellular Therapy Operations and Quality, National Center for Regenerative Medicine, School of Medicine, Case Western Reserve University, Cleveland, Ohio., Sieg SF; Immunology Flow Core, Department of Medicine, Division of Infectious Diseases and HIV Medicine, Case Western Reserve University, Cleveland, Ohio., Clagett B; Immunology Flow Core, Department of Medicine, Division of Infectious Diseases and HIV Medicine, Case Western Reserve University, Cleveland, Ohio., Kleinsorge-Block S; Cellular Therapy Operations and Quality, National Center for Regenerative Medicine, School of Medicine, Case Western Reserve University, Cleveland, Ohio., Somoza-Palacios R; Skeletal Research Center, Department of Biology, College of Arts and Sciences, Case Western Reserve University, Cleveland, Ohio., Singer N; Division of Rheumatology, Department of Internal Medicine, Metrohealth Medical Center, Case Western Reserve University, Cleveland, Ohio., Chance M; Center for Proteomics and Bioinformatics, School of Medicine, Case Western Reserve University, Cleveland, Ohio., Highland KB; Department of Pulmonary/Critical Care, Rheumatic Lung Disease Program, Cleveland Clinic Foundation, Case Western Reserve University, Cleveland, Ohio., Emancipator SN; Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
Publikováno v: Stem cells (Dayton, Ohio) [Stem Cells] 2024 Nov 19. Date of Electronic Publication: 2024 Nov 19.
Zobrazit plný text záznamu
2
Akademický článek
Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells.
Autor: Zeng K; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Huang M; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lyu MA; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Khoury JD; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA., Ahmed S; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Patel KK; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Dropulić B; Caring Cross, Gaithersburg, MD 20878, USA., Reese-Koc J; Department of Cellular Therapy, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA., Caimi PF; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH 44195, USA., Sadeghi T; Cellenkos Inc., Houston, TX 77005, USA., Lima M; Division of Hematology, The Ohio State University College of Medicine, Columbus, OH 43210, USA., Flowers CR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Parmar S; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v: Cells [Cells] 2023 Jul 18; Vol. 12 (14). Date of Electronic Publication: 2023 Jul 18.
Zobrazit plný text záznamu
3
Akademický článek
Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens.
Autor: Wang J; Department of Hematology/Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH, United States., Sanati F; Department of Hematology/Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH, United States., Firoozmand A; Department of Hematology/Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH, United States., Fu P; Case Western Reserve University, Cleveland, OH, United States., Kolk M; Adult Hematologic Malignancies & Stem Cell Transplantation Service, University Hospitals Seidman Cancer Center, Cleveland, OH, United States., Reese-Koc J; Case Western Reserve University, Cleveland, OH, United States., de Lima M; Division of Hematology, Ohio State University, Columbus, OH, United States., Boughan K; Department of Hematology/Oncology, Louis Stokes Veterans Affairs Medical Center, Cleveland, OH, United States., Cooper B; Adult Hematologic Malignancies & Stem Cell Transplantation Service, University Hospitals Seidman Cancer Center, Cleveland, OH, United States., Caimi P; Blood and Marrow Transplant, Cleveland Clinic Foundation, Cleveland, OH, United States., Gallogly M; Adult Hematologic Malignancies & Stem Cell Transplantation Service, University Hospitals Seidman Cancer Center, Cleveland, OH, United States., Otegbeye F; Clinical Research Division, Fred Hutchison Cancer Center, Seattle, WA, United States., Tomlinson B; Adult Hematologic Malignancies & Stem Cell Transplantation Service, University Hospitals Seidman Cancer Center, Cleveland, OH, United States., Metheny L; Adult Hematologic Malignancies & Stem Cell Transplantation Service, University Hospitals Seidman Cancer Center, Cleveland, OH, United States.
Publikováno v: Frontiers in oncology [Front Oncol] 2023 May 03; Vol. 13, pp. 1186532. Date of Electronic Publication: 2023 May 03 (Print Publication: 2023).
Zobrazit plný text záznamu
4
Akademický článek
Low Fouling Polysulfobetaines with Variable Hydrophobic Content.
Autor: Schardt L; Analytical Chemistry - Biointerfaces, Ruhr University Bochum, 44801, Bochum, Germany., Martínez Guajardo A; Institute of Chemistry, University of Potsdam, 14476, Potsdam, Germany., Koc J; Analytical Chemistry - Biointerfaces, Ruhr University Bochum, 44801, Bochum, Germany., Clarke JL; School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK., Finlay JA; School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK., Clare AS; School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK., Gardner H; Center for Corrosion and Biofouling Control, Florida Institute of Technology, Melbourne, FL, 32901, USA., Swain GW; Center for Corrosion and Biofouling Control, Florida Institute of Technology, Melbourne, FL, 32901, USA., Hunsucker K; Center for Corrosion and Biofouling Control, Florida Institute of Technology, Melbourne, FL, 32901, USA., Laschewsky A; Institute of Chemistry, University of Potsdam, 14476, Potsdam, Germany.; Fraunhofer Institute of Applied Polymer Research IAP, 14476, Potsdam, Germany., Rosenhahn A; Analytical Chemistry - Biointerfaces, Ruhr University Bochum, 44801, Bochum, Germany.
Publikováno v: Macromolecular rapid communications [Macromol Rapid Commun] 2022 Jun; Vol. 43 (12), pp. e2100589. Date of Electronic Publication: 2021 Nov 20.
Zobrazit plný text záznamu
5
Akademický článek
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the "First in Cystic Fibrosis" Phase I Clinical Trial (CEASE-CF).
Autor: Bonfield TL; Department of Genetics and Genome Sciences, National Center Regenerative Medicine and Pediatrics, Case Western Reserve University School of Medicine, 10900 Euclid Avenue, BRB 822, Cleveland, OH 444106, USA.; National Center for Regenerative Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 444106, USA.; Department of Pediatric Pulmonary, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA., Sutton MT; Department of Genetics and Genome Sciences, National Center Regenerative Medicine and Pediatrics, Case Western Reserve University School of Medicine, 10900 Euclid Avenue, BRB 822, Cleveland, OH 444106, USA.; National Center for Regenerative Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 444106, USA.; Department of Pediatric Pulmonary, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA.; Saint Jude Children's Research Hospital, Graduate School of Biomedical Sciences, Memphis, TN 38105, USA., Fletcher DR; Department of Genetics and Genome Sciences, National Center Regenerative Medicine and Pediatrics, Case Western Reserve University School of Medicine, 10900 Euclid Avenue, BRB 822, Cleveland, OH 444106, USA.; Department of Pediatric Pulmonary, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA., Reese-Koc J; National Center for Regenerative Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 444106, USA.; University Hospitals Seidman Cancer Center, Cleveland, OH 44106, USA., Roesch EA; Department of Pediatric Pulmonary, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA., Lazarus HM; National Center for Regenerative Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 444106, USA.; University Hospitals Seidman Cancer Center, Cleveland, OH 44106, USA., Chmiel JF; Department of Pediatrics, Riley Hospital for Children at IU Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA., Caplan AI; National Center for Regenerative Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 444106, USA.; Skeletal Research Center, Department of Biology, Case Western Reserve University, Cleveland, OH 44106, USA.
Publikováno v: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Feb 01; Vol. 16 (2). Date of Electronic Publication: 2023 Feb 01.
Zobrazit plný text záznamu
7
Akademický článek
A Phase I Study to Determine the Maximum Tolerated Dose of ex Vivo Expanded Natural Killer Cells Derived from Unrelated, HLA-Disparate Adult Donors.
Autor: Otegbeye F; University Hospitals Seidman Cancer Center, Cleveland, Ohio; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio. Electronic address: fotegbey@fredhutch.org., Cooper B; University Hospitals Seidman Cancer Center, Cleveland, Ohio; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio., Caimi P; University Hospitals Seidman Cancer Center, Cleveland, Ohio; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio., Zamborsky K; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio., Reese-Koc J; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio., Hillian A; University Hospitals Seidman Cancer Center, Cleveland, Ohio., Hernandez-Collazo Y; University Hospitals Seidman Cancer Center, Cleveland, Ohio., Lee G; Case Western Reserve University for Lazarus, Cleveland, Ohio., Boughan K; University Hospitals Seidman Cancer Center, Cleveland, Ohio; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio., Tomlinson B; University Hospitals Seidman Cancer Center, Cleveland, Ohio; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio., Gallogly M; University Hospitals Seidman Cancer Center, Cleveland, Ohio; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio., Metheny L; University Hospitals Seidman Cancer Center, Cleveland, Ohio; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio., Bajor D; University Hospitals Seidman Cancer Center, Cleveland, Ohio; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio., Selfridge J; University Hospitals Seidman Cancer Center, Cleveland, Ohio; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio., Saltzman J; University Hospitals Seidman Cancer Center, Cleveland, Ohio; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio., Lazarus H; Case Western Reserve University for Lazarus, Cleveland, Ohio., de Lima M; University Hospitals Seidman Cancer Center, Cleveland, Ohio; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio., Wald D; University Hospitals Seidman Cancer Center, Cleveland, Ohio; Case Comprehensive Cancer Center for Saltzman, de Lima and Wald, Cleveland, Ohio.
Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2022 May; Vol. 28 (5), pp. 250.e1-250.e8. Date of Electronic Publication: 2022 Feb 14.
Zobrazit plný text záznamu
8
Akademický článek
Optimization of Human Mesenchymal Stem Cells for Rheumatoid Arthritis: Implications for Improved Therapeutic Outcomes.
Autor: Breitman M; Case Western Reserve University and MetroHealth Medical Center, Cleveland, Ohio, USA., Bonfield TL; Case Western Reserve University, Cleveland, Ohio, USA., Caplan AI; Case Western Reserve University, Cleveland, Ohio, USA., Lazarus HM; Case Western Reserve University, Cleveland, Ohio, USA., Haghiac M; MetroHealth Medical Center, Cleveland, Ohio, USA., LaSalvia S; MetroHealth Medical Center, Cleveland, Ohio, USA., Reese-Koc J; Case Western Reserve University, Cleveland, Ohio, USA., Singer NG; Case Western Reserve University and MetroHealth Medical Center, Cleveland, Ohio, USA.
Publikováno v: ACR open rheumatology [ACR Open Rheumatol] 2022 Feb; Vol. 4 (2), pp. 152-160. Date of Electronic Publication: 2021 Nov 18.
Zobrazit plný text záznamu
9
Akademický článek
Reduction of biofilm accumulation by constant and alternating potentials in static and dynamic field experiments.
Autor: Schwarze J; Analytical Chemistry - Biointerfaces, Ruhr University Bochum, Bochum, Germany., Koc J; Analytical Chemistry - Biointerfaces, Ruhr University Bochum, Bochum, Germany., Koschitzki F; Analytical Chemistry - Biointerfaces, Ruhr University Bochum, Bochum, Germany., Gardner H; Center for Corrosion and Biofouling Control, Florida Institute of Technology, Melbourne, FL, USA., Hunsucker KZ; Center for Corrosion and Biofouling Control, Florida Institute of Technology, Melbourne, FL, USA., Swain GW; Center for Corrosion and Biofouling Control, Florida Institute of Technology, Melbourne, FL, USA., Rosenhahn A; Analytical Chemistry - Biointerfaces, Ruhr University Bochum, Bochum, Germany.
Publikováno v: Biofouling [Biofouling] 2022 Feb; Vol. 38 (2), pp. 119-130. Date of Electronic Publication: 2022 Mar 04.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje